28091848|t|A novel combination treatment to stimulate bone healing and regeneration under hypoxic conditions: photobiomodulation and melatonin
28091848|a|Melatonin has anabolic effects on the bone, even under hypoxia, and laser irradiation has been shown to improve osteoblastic differentiation. The aim of this study was to investigate whether laser irradiation and melatonin would have synergistic effects on osteoblastic differentiation and mineralization under hypoxic conditions. MC3T3-E1 cells were exposed to 1% oxygen tension for the hypoxia condition. The cells were divided into four groups: G1 - osteoblast differentiation medium only (as the hypoxic condition), G2 - treatment with 50 μM melatonin only, G3 - laser irradiation (808 nm, 80 mW, GaAlAs diode) only, and G4 - treatment with 50 μM melatonin and laser irradiation (808 nm, 80 mW, GaAlAs diode). Immunoblotting showed that osterix expression was markedly increased in the melatonin - treated and laser-irradiated cells at 48 and 72 h. In addition, alkaline phosphatase activity significantly increased and continued to rise throughout the experiment. Alizarin Red staining showed markedly increased mineralized nodules as compared with only melatonin - treated or laser-irradiated cells at day 7, which significantly increased by day 14. Moreover, when melatonin - treated cells were laser-irradiated, the differentiation and mineralization of cells were found to involve p38 MAPK and PRKD1 signaling mechanisms. However, the enhanced effects of laser irradiation with melatonin were markedly inhibited when the cells were treated with luzindole, a selective melatonin receptor antagonist. Therefore, we concluded that laser irradiation could promote the effect of melatonin on the differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions, and that this process is mediated through melatonin 1/2 receptors and PKRD / p38 signaling pathways.
28091848	2	7	novel	T080	C0205314
28091848	20	29	treatment	T169	C1522326
28091848	33	42	stimulate	T061	C1292856
28091848	43	55	bone healing	T033	C1321023
28091848	60	72	regeneration	T042	C0005972
28091848	79	97	hypoxic conditions	T046	C0242184
28091848	99	117	photobiomodulation	T061	C4019433
28091848	122	131	melatonin	T109,T121,T125	C0025219
28091848	132	141	Melatonin	T109,T121,T125	C0025219
28091848	146	162	anabolic effects	T039	C3179309
28091848	170	174	bone	T024	C0391978
28091848	187	194	hypoxia	T046	C0242184
28091848	200	217	laser irradiation	T061	C0871799
28091848	244	272	osteoblastic differentiation	T043	C1159974
28091848	278	281	aim	T078	C1947946
28091848	290	295	study	T062	C2603343
28091848	303	314	investigate	T169	C1292732
28091848	323	340	laser irradiation	T061	C0871799
28091848	345	354	melatonin	T109,T121,T125	C0025219
28091848	366	377	synergistic	T080	C2986495
28091848	378	385	effects	T080	C1280500
28091848	389	417	osteoblastic differentiation	T043	C1159974
28091848	422	436	mineralization	T042	C2350989
28091848	443	461	hypoxic conditions	T046	C0242184
28091848	463	477	MC3T3-E1 cells	T025	C0007634
28091848	497	511	oxygen tension	T033	C0860755
28091848	520	537	hypoxia condition	T046	C0242184
28091848	543	548	cells	T025	C0007634
28091848	572	578	groups	T078	C0441833
28091848	580	582	G1	T078	C0441833
28091848	585	611	osteoblast differentiation	T043	C1159974
28091848	612	618	medium	T130	C0010454
28091848	632	649	hypoxic condition	T046	C0242184
28091848	652	654	G2	T078	C0441833
28091848	657	666	treatment	T169	C1522326
28091848	678	687	melatonin	T109,T121,T125	C0025219
28091848	694	696	G3	T078	C0441833
28091848	699	716	laser irradiation	T061	C0871799
28091848	733	745	GaAlAs diode	T074	C0392255
28091848	757	759	G4	T078	C0441833
28091848	762	771	treatment	T169	C1522326
28091848	783	792	melatonin	T109,T121,T125	C0025219
28091848	797	814	laser irradiation	T061	C0871799
28091848	831	843	GaAlAs diode	T074	C0392255
28091848	846	860	Immunoblotting	T059	C0020985
28091848	873	880	osterix	T116	C1312518
28091848	881	891	expression	T045	C1171362
28091848	905	914	increased	T081	C0205217
28091848	922	931	melatonin	T109,T121,T125	C0025219
28091848	934	941	treated	T169	C1522326
28091848	946	962	laser-irradiated	T061	C0871799
28091848	963	968	cells	T025	C0007634
28091848	998	1018	alkaline phosphatase	T116,T126	C0002059
28091848	1019	1027	activity	T052	C0441655
28091848	1042	1051	increased	T081	C0205217
28091848	1056	1065	continued	T078	C0549178
28091848	1089	1099	experiment	T062	C0681814
28091848	1101	1122	Alizarin Red staining	T059	C1318906
28091848	1139	1148	increased	T081	C0205217
28091848	1149	1160	mineralized	T042	C2350989
28091848	1161	1168	nodules	T046	C0035441
28091848	1191	1200	melatonin	T109,T121,T125	C0025219
28091848	1203	1210	treated	T169	C1522326
28091848	1214	1230	laser-irradiated	T061	C0871799
28091848	1231	1236	cells	T025	C0007634
28091848	1267	1276	increased	T081	C0205217
28091848	1303	1312	melatonin	T109,T121,T125	C0025219
28091848	1315	1322	treated	T169	C1522326
28091848	1323	1328	cells	T025	C0007634
28091848	1334	1350	laser-irradiated	T061	C0871799
28091848	1356	1371	differentiation	T043	C0007589
28091848	1376	1390	mineralization	T042	C2350989
28091848	1394	1399	cells	T025	C0007634
28091848	1422	1430	p38 MAPK	T116,T126	C1120843
28091848	1435	1440	PRKD1	T116,T126	C2987025
28091848	1441	1461	signaling mechanisms	T043	C0037083
28091848	1476	1484	enhanced	T052	C2349975
28091848	1485	1495	effects of	T080	C1704420
28091848	1496	1513	laser irradiation	T061	C0871799
28091848	1519	1528	melatonin	T109,T121,T125	C0025219
28091848	1543	1552	inhibited	T080	C0311403
28091848	1562	1567	cells	T025	C0007634
28091848	1573	1580	treated	T169	C1522326
28091848	1586	1595	luzindole	T109	C0065275
28091848	1609	1638	melatonin receptor antagonist	T121	C2917356
28091848	1669	1686	laser irradiation	T061	C0871799
28091848	1705	1714	effect of	T080	C1704420
28091848	1715	1724	melatonin	T109,T121,T125	C0025219
28091848	1732	1747	differentiation	T043	C0007589
28091848	1752	1766	mineralization	T042	C2350989
28091848	1770	1784	MC3T3-E1 cells	T025	C0007634
28091848	1791	1809	hypoxic conditions	T046	C0242184
28091848	1853	1876	melatonin 1/2 receptors	T116,T192	C0065911
28091848	1881	1885	PKRD	T116,T126	C2987025
28091848	1888	1891	p38	T116,T126	C1120843
28091848	1892	1910	signaling pathways	T044	C0037080